Bryan W Day

Bryan W Day

UNVERIFIED PROFILE

Are you Bryan W Day?   Register this Author

Register author
Bryan W Day

Bryan W Day

Publications by authors named "Bryan W Day"

Are you Bryan W Day?   Register this Author

36Publications

547Reads

13Profile Views

Circulating biomarkers in patients with glioblastoma.

Br J Cancer 2020 Feb 31;122(3):295-305. Epub 2019 Oct 31.

Saliva and Liquid Biopsy Translational Research Team, The School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, QLD, 4059, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-019-0603-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000822PMC
February 2020

Transcription factors NFIA and NFIB induce cellular differentiation in high-grade astrocytoma.

J Neurooncol 2020 Jan 23;146(1):41-53. Epub 2019 Nov 23.

The Queensland Brain Institute, The University of Queensland, Brisbane, QLD, 4072, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-019-03352-3DOI Listing
January 2020

Q-Cell Glioblastoma Resource: Proteomics Analysis Reveals Unique Cell-States are Maintained in 3D Culture.

Cells 2020 Jan 21;9(2). Epub 2020 Jan 21.

Cell and Molecular Biology Department, QIMR Berghofer Medical Research Institute, Sid Faithfull Brain Cancer Laboratory, Brisbane, QLD 4006, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cells9020267DOI Listing
January 2020

Phase I and phase II sonidegib and vismodegib clinical trials for the treatment of paediatric and adult MB patients: a systemic review and meta-analysis.

Acta Neuropathol Commun 2019 07 30;7(1):123. Epub 2019 Jul 30.

Department of Cell and Molecular Biology, QIMR Berghofer Medical Research Institute, Brisbane, 4006, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40478-019-0773-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668073PMC
July 2019

Changes in cell morphology guide identification of tubulin as the off-target for protein kinase inhibitors.

Pharmacol Res 2018 08 23;134:166-178. Epub 2018 Jun 23.

The University of Sydney, Faculty of Medicine and Health, Charles Perkins Centre, NSW 2006, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.phrs.2018.06.023DOI Listing
August 2018

Dianthin-30 or gelonin versus monomethyl auristatin E, each configured with an anti-calcitonin receptor antibody, are differentially potent in vitro in high-grade glioma cell lines derived from glioblastoma.

Cancer Immunol Immunother 2017 Sep 13;66(9):1217-1228. Epub 2017 May 13.

Department of Medicine/Cardiology (Austin Health, Heidelberg), University of Melbourne, Lance Townsend Building, Level 10, Austin Campus, Studley Road, Heidelberg, VIC, 3084, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-017-2013-zDOI Listing
September 2017

Development and Biological Evaluation of a Photoactivatable Small Molecule Microtubule-Targeting Agent.

ACS Med Chem Lett 2017 Apr 15;8(4):395-400. Epub 2017 Mar 15.

School of Medical Sciences and Charles Perkins Centre, The University of Sydney, Sydney, NSW 2006, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acsmedchemlett.6b00483DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392771PMC
April 2017

Structural Optimization and Pharmacological Evaluation of Inhibitors Targeting Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases (DYRK) and CDC-like kinases (CLK) in Glioblastoma.

J Med Chem 2017 03 28;60(5):2052-2070. Epub 2017 Feb 28.

Oncogenic Signaling Laboratory, Centre for Cancer Research, Hudson Institute of Medical Research , 27 Wright Street, Clayton, Victoria 3168, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.jmedchem.6b01840DOI Listing
March 2017

Increased sensitivity to ionizing radiation by targeting the homologous recombination pathway in glioma initiating cells.

Mol Oncol 2014 Dec 27;8(8):1603-15. Epub 2014 Jun 27.

QIMR Berghofer Medical Research Institute, 300 Herston Road, Herston, Queensland 4029, Australia; The University of Queensland Centre for Clinical Research, Royal Brisbane and Women's Hospital Campus, Herston, Queensland 4029, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1016/j.molonc.2014.06.012
Publisher Site
http://dx.doi.org/10.1016/j.molonc.2014.06.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5528585PMC
December 2014

Eph family co-expression patterns define unique clusters predictive of cancer phenotype.

Growth Factors 2014 Dec 20;32(6):254-64. Epub 2014 Nov 20.

Brain Cancer Research Unit & Leukaemia Foundation Research Unit, QIMR Berghofer Medical Research Institute , Brisbane, Queensland , Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/08977194.2014.984807DOI Listing
December 2014

The tumor suppressor microRNA, miR-124a, is regulated by epigenetic silencing and by the transcriptional factor, REST in glioblastoma.

Tumour Biol 2014 Feb 26;35(2):1459-65. Epub 2013 Sep 26.

Prince of Wales Clinical School, Adult Cancer Program, Cure For Life Neuro-Oncology Group, Lowy Cancer Research Centre, University of New South Wales, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13277-013-1200-6DOI Listing
February 2014

NFIB-mediated repression of the epigenetic factor Ezh2 regulates cortical development.

J Neurosci 2014 Feb;34(8):2921-30

Queensland Brain Institute, Institute for Molecular Bioscience, and The School of Biomedical Sciences, The University of Queensland, Brisbane, Australia 4069, QIMR Berghofer Medical Research Institute, Brisbane, Australia 4029, and Department of Biochemistry, Program in Genetics, Genomics and Bioinformatics, Center of Excellence in Bioinformatics and Life Sciences, State University of New York at Buffalo, Buffalo, New York 14203.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1523/JNEUROSCI.2319-13.2014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931505PMC
February 2014

Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake.

Nat Neurosci 2013 Oct 1;16(10):1373-82. Epub 2013 Sep 1.

1] Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine at Case Western Reserve University, Cleveland, Ohio, USA. [2] Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nn.3510DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930177PMC
October 2013

A role for homologous recombination and abnormal cell-cycle progression in radioresistance of glioma-initiating cells.

Mol Cancer Ther 2012 Sep 6;11(9):1863-72. Epub 2012 Jul 6.

Queensland Institute of Medical Research, University of Queensland Centre for Clinical Research, Royal Brisbane Hospital Campus, Herston, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-11-1044DOI Listing
September 2012

Activation of ephrin A proteins influences hematopoietic stem cell adhesion and trafficking patterns.

Exp Hematol 2010 Nov 23;38(11):1087-98. Epub 2010 Jul 23.

Leukaemia Foundation of Queensland Research Unit, Queensland Institute of Medical Research, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2010.07.007DOI Listing
November 2010

Ephrin expression and function in cancer.

Future Oncol 2010 Jan;6(1):165-76

Leukaemia Foundation Research Unit, Queensland Institute of Medical Research, P.O. Royal Brisbane Hospital, Queensland, 4029, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.09.146DOI Listing
January 2010

Eph/Ephrin membrane proteins: a mammalian expression vector pTIg-BOS-Fc allowing rapid protein purification.

Protein Pept Lett 2006 ;13(2):193-6

Leukaemia Foundation of Queensland Laboratory, Queensland Institute of Medical Research. P.O Royal Brisbane Hospital, Queensland 4029, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/092986606775101625DOI Listing
July 2006